HNB
SANA icon

Huntington National Bank’s Sana Biotechnology SANA Stock Holding History

Huntington National Bank’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4K Buy
+400
New +$1.29K ﹤0.01% 2517

Other funds holding SANA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Huntington National Bank's SANA Position: Q2 2026 in Review

Huntington National Bank opened a new position in Sana Biotechnology (SANA) in Q2 2026: 400 shares worth $1.4K. The stake represents ﹤0.01% of the portfolio and ranks #2517 among its holdings.

149 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Huntington National Bank held 400 shares of Sana Biotechnology worth $1.4K as of Q2 2026.
  • Sana Biotechnology was a new Huntington National Bank position in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2517 holding.
  • 149 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.